Insulet Wins $452 Million in Landmark Trade Secrets Lawsuit Against Eoflow
In a significant legal victory, Insulet Corp. was awarded $452 million in damages after a federal jury found that Eoflow Co., a South Korean medical device company, engaged in trade secret misappropriation. The verdict came after a closely watched trial that highlighted the fierce competition in the medical device sector, particularly in technologies related to diabetes management. The lawsuit, initiated by Insulet, accused Eoflow of illegally acquiring and using Insulet’s proprietary information to develop and market its own competing product. The core of the dispute centered around technology for wearable insulin pumps, which are crucial … Read more